Cytotoxic, cytostatic, and keratolytic activity of anti-dandruff shampoo formulations
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20230036Keywords:
Selenium sulfide, Ketoconazole, Zinc pyrithione, Immortalized keratinocytes, Human dermal fibroblasts, Cytostatic activity, Keratolytic activityAbstract
Background: Dandruff is characterized by increased sebum production, yeast colonization, and hyper-keratinization leading to an itchy-flaky scalp. Ancillary non-microbial reasons for flaky scalp include ultraviolet rays and excessive heat from the sun. Thus, apart from traditional anti-fungal activity, anti-dandruff formulations should also possess the keratolytic activity and should be safe to use.
Methods: Selsun, a shampoo formulation with 2.5% selenium sulfide (SS2.5), was tested in-vitro for its cytotoxic and cytostatic activities via cell viability of primary human dermal fibroblasts (HDFs). Its keratolytic activity was determined by assessing anti-proliferative activity on immortalized human keratinocyte (HaCaT) cell line. The shampoo was compared with 3 other shampoo formulations, one containing 2% ketoconazole (K2), second containing 2% ketoconazole with 1% zinc pyrithione (K2ZP1), and third containing 1% zinc pyrithione (ZP1).
Results: Of the tested samples, SS2.5 and K2ZP1 showed cytostatic and keratolytic activity where the IC50 values on normal HDFs i.e., 0.521 mg/ml and 0.220 mg/ml, respectively, were higher than those on HaCaT cells (0.162 mg/ml and 0.198 mg/ml, respectively). SS2.5 displayed the highest keratolytic activity at IC50 of 0.162 mg/ml, followed by K2ZP1 (0.198 mg/ml) and K2 (0.267 mg/ml). On normal HDFs, SS2.5 showed the highest IC50 value (0.521 mg/ml), followed by K2 at 0.264 mg/mL, K2ZP1 at 0.220 mg/ml, and ZP1 at 0.139 mg/ml.
Conclusions: SS2.5 was found to possess the highest cytostatic and keratolytic activities among all the shampoo formulations tested, thereby confirming its safety profile.
Metrics
References
Saint‐Léger D. Dandruff (Pityriasis Capitis Simplex): Of Yeasts and Men. The Science of Hair Care (Bouillon, C. and Wilkinson, J., Eds.) Taylor and Francis, New York. 2005;670-97.
Piérard-Franchimont C, Piérard GE. Certainties, controversies and semantic confusions around dandruff. Skin. 1998;1:16-9.
Piérard-Franchimont C, Xhauflaire-Uhoda E, Piérard GE. Revisiting dandruff. Int J Cosmet Sci. 2006;28(5):311-8.
Danby FW, Maddin WS, Margesson LJ, Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol. 1993;29(6):1008-12.
Pochi PE, Strauss JS, Downing DT. Age-related changes in sebaceous gland activity. Invest Dermatol. 1979;73(1):108-11.
Piérard-Franchimont C, Hermanns J, Degreef H, Piérard G. From axioms to new insights into dandruff. Dermatology. 2000;200(2):93-8.
Grimshaw SG, Smith AM, Arnold DS, Xu E, Hoptroff M, Murphy B. The diversity and abundance of fungi and bacteria on the healthy and dandruff affected human scalp. PLoS One. 2019;14(12):e0225796.
Donnarumma G, Paoletti I, Buommino E, Orlando M, Tufano MA, Baroni A. Malassezia furfur induces the expression of β-defensin-2 in human keratinocytes in a protein kinase C-dependent manner. Arch Dermatol Res. 2004;295(11):474-81.
Piérard GE, Piérard-Franchimont C. Squamometry in acute photodamage. Skin Res Technol. 1995;1(3):137-9.
Velegraki A, Cafarchia C, Gaitanis G, Iatta R, Boekhout T. Malassezia infections in humans and animals: Pathophysiology, detection, and treatment. PLoS Pathol. 2015;11(1):e1004523.
Dawson TL. Malassezia globosa and restricta: Breakthrough Understanding of the etiology and treatment of dandruff and seborrheic dermatitis through whole-genome analysis. J Invest Dermatol Symp Proc. 2007;12(2):15-9.
Jourdain R, Moga A, Vingler P, el Rawadi C, Pouradier F, Souverain L, et al. Exploration of scalp surface lipids reveals squalene peroxide as a potential actor in dandruff condition. Arch Dermatol Res. 2016;308(3):53-63.
Gupta PK, Periman LM, Lain E, Donnenfeld E, Hovanesian J, Kim T, et al. Meibomian gland dysfunction: A dermatological perspective on pathogenesis and treatment outlook. Clin Ophthalmol. 2021;15:4399-404.
Epstein-Barash H, Rapaport H, Alster Y, Rafaeli O. Keratolytic and keratostatic activity of selenium disulfide and its disease modifying role in meibomian gland disease. Investig Ophthalmol Visual Sci. 2021;62:692.
Plewig G, Klingman AM. The effect of selenium sulfide on epidermal turnover of normal and dandruff scalps. J Soc Cosmet Chemists. 1969;20:767-75.
Tse WP, Cheng CH, Che CT, Zhao M, Lin ZX. Induction of apoptosis underlies the Radix Rubiae-mediated anti-proliferative action on human epidermal keratinocytes: Implications for psoriasis treatment. Int JMol Med. 2007;20(5):663-72.
Ranganathan S, Mukhopadhyay T. Dandruff: The most commercially exploited skin disease. Indian J Dermatol. 2010;55(2):130-4.
Huang TH, Lin CF, Alalaiwe A, Yang SC, Fang JY. Apoptotic or antiproliferative activity of natural products against keratinocytes for the treatment of psoriasis. Int J Mol Sci. 2019;20(10):2558.
Narshana M, Ravikumar P. An overview of dandruff and novel formulations as a treatment strategy. Int J Pharm Sci Res. 2017;9(2):417-31.
Kummar S, Gutierrez M, Doroshow JH, Murgo AJ. Drug development in oncology: classical cytotoxics and molecularly targeted agents. Br J Clin Pharmacol. 2006;62(1):15-26.
Piérard-Franchimont C, Goffin V Decroix J, Piérard GE. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Physiol. 2002;15(6):434-41.
Utgikar PJ, Kadam JH, Rambhiya SJ, Inamdar VM, Nagda PD, Barve SS, et al. Titanium dioxide and its effect on human health and environment - An in vitro study. Eur J Biol Biotechnol. 2022;3(2):20-4.
Robles-Escajeda E, Martínez A, Varela-Ramirez A, Sánchez-Delgado RA, Aguilera RJ. Analysis of the cytotoxic effects of ruthenium–ketoconazole and ruthenium–clotrimazole complexes on cancer cells. Cell Biol Toxicol. 2013;29(6):431-43.
Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1(3):1112-6.